MASSA, GIACOMO
MASSA, GIACOMO
Dipartimento di Scienze Cliniche e di Comunità
Application and accuracy of the EAPC/IASP diagnostic algorithm for neuropathic cancer pain and quantitative sensory testing profile in patients with pain due to cancer
2024 M. Shkodra, M. Mulvey, M. Fallon, C. Brunelli, E. Zecca, P. Bracchi, M. Caputo, G. Massa, S. Lo Dico, R. Rolke, S. Kaasa, A. Caraceni
Anticancer Drugs-Related Hypogonadism in Male Patients with Advanced Cancers on Active Treatment: A Systematic Review
2024 G. Massa, L. Zambelli, E. Zecca, M. Shkodra, G. Tinè, A. Caraceni
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion
2023 M. Aldea, A. Marinello, M. Duruisseaux, W. Zrafi, N. Conci, G. Massa, G. Metro, I. Monnet, P. Gomez Iranzo, F. Tabbo, E. Bria, F. Guisier, D. Vasseur, C.R. Lindsay, S. Ponce-Aix, S. Cousin, F. Citarella, V. Fallet, J.N. Minatta, A. Eisert, H. de Saint Basile, C. Audigier-Valette, L. Mezquita, A. Calles, G. Mountzios, M. Tagliamento, J. Remon Masip, J. Raimbourg, S. Terrisse, A. Russo, D. Cortinovis, P. Rochigneux, D.J. Pinato, A. Cortellini, C. Leonce, A. Gazzah, M. Ghigna, R. Ferrara, F.G. Dall'Olio, F. Passiglia, V. Ludovini, F. Barlesi, E. Felip, D. Planchard, B. Besse
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
2023 C. Proto, S. Manglaviti, G. Lo Russo, M. Musca, G. Galli, M. Imbimbo, M. Perrino, N. Cordua, E. Rulli, Z. Ballatore, A.D. Maso, A. Chella, A. Sbrana, A. Prelaj, R. Ferrara, M. Occhipinti, M. Brambilla, A. De Toma, L. Mazzeo, T. Beninato, D. Signorelli, G. Massa, F.G. Greco, G. Calareso, D. Miliziano, R.M. Di Mauro, G. Mella, A. Lucarelli, A. Paggio, F. Galli, V. Torri, F.G.M. de Braud, G. Pasello, I. Petrini, R. Berardi, M. Ganzinelli, M.C. Garassino, P.A. Zucali
Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy
2022 C.I. Ripamonti, G. Massa, D. Insolvibile, M. Guglielmo, G. Miccinesi, C. Regalia, E. Saita, F. Pagnini
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy
2022 A. Prelaj, M. Boeri, A. Robuschi, R. Ferrara, C. Proto, G. Lo Russo, G. Galli, A. De Toma, M. Brambilla, M. Occhipinti, S. Manglaviti, T. Beninato, A. Bottiglieri, G. Massa, E. Zattarin, R. Gallucci, E.G. Galli, M. Ganzinelli, G. Sozzi, F.G.M. de Braud, M.C. Garassino, M. Restelli, A.L.G. Pedrocchi, F. Trovo'
Uterine Tumor Resembling Sex-Cord Tumors of the Ovary (Utrosct): A Case of Long-Term Response to Pazopanib
2022 G. Massa, C. Pircher, A. Tessari, S. Damian, M. Duca, E. Tamborini, F. Perrone, B. Paolini, A. Martinetti, E. Sottotetti, F. de Braud, S. Cresta
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP)
2022 A. Passaro, G.L. Russo, F. Passiglia, M. D'Arcangelo, A. Sbrana, M. Russano, L. Bonanno, R. Giusti, G. Metro, F. Bertolini, S. Grisanti, A. Carta, F. Cecere, M. Montrone, G. Massa, F. Perrone, F. Simionato, G. Guaitoli, V. Scotti, C. Genova, A. Lugini, L. Bonomi, I. Attili, F. de Marinis
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy
2022 E. Zattarin, S. Manglaviti, G. Apollonio, T. Beninato, L. Mazzeo, G. Massa, A. Bottiglieri, E. Galli, A. De Toma, M. Occhipinti, M. Brambilla, R. Ferrara, M. Ganzinelli, C. Proto, M.C. Garassino, F. de Braud, G. Lo Russo, A. Prelaj
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
2022 S. Manglaviti, M. Brambilla, D. Signorelli, R. Ferrara, G. Lo Russo, C. Proto, G. Galli, A. De Toma, M. Occhipinti, G. Viscardi, T. Beninato, E. Zattarin, M. Bini, R. Lobefaro, G. Massa, A. Bottiglieri, G. Apollonio, E. Sottotetti, R.M. Di Mauro, B. Trevisan, M. Ganzinelli, A. Fabbri, F.G.M. de Braud, M.C. Garassino, A. Prelaj
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers
2021 R. Lobefaro, G. Viscardi, R. Di Liello, G. Massa, M.L. Iacovino, F. Sparano, C.M. Della Corte, R. Ferrara, D. Signorelli, C. Proto, A. Prelaj, G. Galli, A. De Toma, M. Brambilla, M. Ganzinelli, B. Trevisan, F. Ciardiello, F. De Braud, F. Morgillo, M.C. Garassino, G. Lo Russo
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
2021 S. Cavalieri, E. Colombo, A. Bottiglieri, G. Massa, F. Platini, A. Ottini, D. Filippini, E. Zattarin, C. Bergamini, C. Resteghini, S. Alfieri, V. Di Martino, V. Tiraferri, L. Locati, L. Licitra
Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression
2021 A. Prelaj, C.C. Pircher, G. Massa, V. Martelli, G. Corrao, G.L. Russo, C. Proto, R. Ferrara, G. Galli, A. De Toma, C. Genova, B.A. Jereczek-Fossa, F. de Braud, M.C. Garassino, S.E. Rebuzzi